DekaBank Deutsche Girozentrale
EXAS

DekaBank Deutsche Girozentrale’s Exact Sciences EXAS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-58,333
Closed -$3.83M – 1188
2025
Q4 		$3.83M Hold
58,333
– – 0.01% 634
2025
Q3 		$3.1M Hold
58,333
– – 0.01% 671
2025
Q2 		$3.13M Buy
58,333
+217
+0.4% +$11K 0.01% 663
2025
Q1 		$2.51M Sell
58,116
-217
-0.4% -$11K ﹤0.01% 692
2024
Q4 		$3.32M Hold
58,333
– – 0.01% 655
2024
Q3 		$3.82M Sell
58,333
-1,558
-3% -$87.9K 0.01% 639
2024
Q2 		$2.68M Buy
59,891
+1,775
+3% +$97.7K ﹤0.01% 696
2024
Q1 		$3.92M Buy
58,116
+16,980
+41% +$1.07M 0.01% 629
2023
Q4 		$3.09M Sell
41,136
-2,787
-6% -$183K 0.01% 684
2023
Q3 		$3.03M Sell
43,923
-1,462
-3% -$124K 0.01% 645
2023
Q2 		$4.28M Buy
45,385
+249
+0.6% +$19.4K 0.01% 581
2023
Q1 		$2.97M Buy
45,136
+580
+1% +$37.3K 0.01% 645
2022
Q4 		$2.21M Sell
44,556
-3,909
-8% -$160K 0.01% 701
2022
Q3 		$1.6M Buy
48,465
+385
+0.8% +$15.9K ﹤0.01% 760
2022
Q2 		$1.93M Buy
48,080
+884
+2% +$47.3K 0.01% 737
2022
Q1 		$3.39M Buy
47,196
+5,424
+13% +$396K 0.01% 639
2021
Q4 		$3.02M Buy
41,772
+2,830
+7% +$250K 0.01% 679
2021
Q3 		$3.57M Buy
38,942
+733
+2% +$77.4K 0.01% 608
2021
Q2 		$4.86M Buy
38,209
+2,979
+8% +$356K 0.01% 525
2021
Q1 		$4.35M Sell
35,230
-231
-0.7% -$31.6K 0.01% 521
2020
Q4 		$4.68M Buy
35,461
+4,601
+15% +$556K 0.02% 472
2020
Q3 		$3.11M Buy
30,860
+22,687
+278% +$1.96M 0.01% 499
2020
Q2 		$699K Buy
8,173
+231
+3% +$18.5K ﹤0.01% 733
2020
Q1 		$459K Sell
7,942
-306
-4% -$24.8K ﹤0.01% 776
2019
Q4 		$773K Sell
8,248
-3,164
-28% -$278K ﹤0.01% 746
2019
Q3 		$1.07M Buy
11,412
+1,402
+14% +$160K 0.01% 655
2019
Q2 		$1.22M Buy
+10,010
New +$1.01M 0.01% 742
2018
Q2 		– Sell
-850
Closed -$34K – 1224
2018
Q1 		$34K Buy
+850
New +$41.5K ﹤0.01% 1116
2015
Q4 		– Sell
-170,700
Closed -$3.07M – 1091
2015
Q3 		$3.07M Buy
170,700
+137,200
+410% +$3.15M 0.04% 398
2015
Q2 		$996K Buy
33,500
+13,500
+68% +$339K 0.01% 570
2015
Q1 		$441K Buy
+20,000
New +$507K 0.01% 749

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

DekaBank Deutsche Girozentrale's EXAS Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 58,333 shares — an estimated $3.83M sold.

DekaBank Deutsche Girozentrale first reported a position in EXAS in Q1 2015 and held it in 31 quarters. The position peaked at $4.86M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • DekaBank Deutsche Girozentrale reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 58,333 Exact Sciences shares in Q1 2026, an estimated $3.83M.
  • DekaBank Deutsche Girozentrale first reported a position in Exact Sciences in Q1 2015 and held it in 31 quarters.
  • DekaBank Deutsche Girozentrale's Exact Sciences position peaked at $4.86M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.